RESEARCH GRANT AWARDS

Investigating the role of MAML3 in neuroendocrine tumorigenesis

Targeting Eya2 to inhibit c-Myc driven Medulloblastoma Tumor

CARD10 and NFkB signaling in melanoma: Implications for immunotherapy

Exploiting Patient Derived Cancer Models for Novel Immunotherapy Regimens

Identification of TME-Derived Pathways for Co-Targeting in FGFR1-Dependent Lung Cancers

Mechanisms of Resistance to T Cell-Mediated Immunotherapy in Non-Small Cell Lung Cancer

Targeting paracrine stromal factors induced by P13K inhibitor therapy in head and neck cancer

Targeting the novel immune checkpoint CD112R for cancer therapy

Role of Antitumor Chemokines in Clearance of Head and Neck Cancer

Role of TRKB/BDNF axis in brain metastatic breast cancer

Role of microRNA methylation and its application as a biomarker in head and neck cancer

Examining oncogenic clonal expansions in the context of aging

Elucidating the Mechanism by which ESE-1 Controls Estrogen Mediated Tumorigenesis in HER2 + ER + Luminal B Human Breast Cancer

Cancer Research Summer Fellowship Program

Therapeutic targeting of organ specific tumor growth and metastases through functional genomics

Novel genes mediating cancer cell survival and proliferation in hypoxic conditions

The Role of ETV6 in B lymphopoiesis

p53 in melanoma

Examining the role of Mucin-2 in breast cancer

Integrating Transcriptional Regulatory And Metabolic Networks To Characterize Bladder Cancer Cellular Response to Chemotherapies

Determining the utility of UV photography as a quantitative tool for evaluating sun exposure history of children and adolescents

Cancer Research Summer Fellowship Program

Homozygously deleted chromosomal changes in metastatic melanoma

Tumor-derived LPA immune suppression of CD8 T cell tumor immunity

The role of the Androgen Receptor in obesity-associated postmenopausal breast cancer

Combination Therapies for Young Patients with late state colorectal cancer

A novel preclinical model to test Iloprost and PPAR delta antagonist in lung cancer chemoprevention

Role of EphB4 in radiosensitization in PDX model of head and neck cancer

Identification and characterization of GON4L as a novel regulator of oncogene CD24 in bladder cancer

Novel Assessment of Neuropsychological Difficulties in Children (NAND-Child)

Targeting breast cancer stem cells by inhibiting glucose metabolism

The anti-cancer mechanism of Il-37

Activation of NK cells for immunotherapy of lung tumors

Identifying Molecular Targets in Melanoma Resistant to Braf/Mek Combination Therapy

Role of Mammalian Sterile 20 like kinase 4 (MSTA) in Pediatric Brain Cancer

Approaches to Targeted Therapy in Adrenal Carcinogenesis

Systems analysis of EGFR-inhibitor induced kinome reprograming and EMT in non-small cell lung cancer

Selective targeting of drug-induced autophagy to improve cancer therapy

Redox-targeted therapy for the treatment of FLT3 mutated leukemia

How does miRNA modulation of mRNA structure regulate production of a pro-tumor chemokine receptor?

Leukemia-cell Calcineurin as a central mediator of immune evasion

Consequences of TP63 loss on human skin squamous cell carcinogenesis

Cancer Research Summer Fellowship Program

A Novel Approach to Reveal the Impact of Genetic Mutations on Cancer Genome Stability

Functional analysis of EBF1:PDGFRB, a novel oncoprotein

Quiescent estrogen receptor positive cells as a source of breast cancer recurrence

Combined ATRA and Ipillmuma treatment to reduce immunosuppression in melanoma patients

Role of PBRM1 mutation in clear cell renal cell carcinoma

Evaluation of pharmacologic inhibition of histone demethylases in Ewing Sarcoma

Developing stapled peptides for breast cancer theraphy

The effect of inhibiting splicing factor Snu114 in cancer

Grhl2 Developmental Network to Identify Novel Suppressors of EMT in Breast Cancer

Characterizing the activation status of inflammatory infiltrates in persistent and regressive premalignanat bronchial dysplasia

The function of tumor infiltrating B cells in non small cell lung cancer patients

Kinome Essential Screen for Discovery of Novel Targets in Small Cell Lung Cancer

Elucidating the roles of midbodies during squamous cell carcinoma progression

Novel Therapeutic Targets in Ezh2-Inactivated Acoute Leukemia

HAS2 is a critical effector for AGL mediated regulation of tumor growth

Targeting Src kinase with dasatinib in thryoid cancer

Autophagy and RIP#-dependent necrosis in cancer chemotherapy

The Roles of APOBEC3 in Human Papillomavirus Infection and Oncogenesis

Role of hypoxic signaling in influencing T cell mediated cancer immunotherapy

Unique patterns of progression in recurrent pediatric Ependymoma

Metabolomics of primary and recurrent high grade gilomas: a role for the UPR

In Vivo modeling of salivary gland tumor formation progression

Genomic sequencing-based predictive biomarker development for targeted anti- cancer therapies

AGL, a glycogen debranching gene is a novel suppressor of bladder cancer growth

Role of HIF in regulating RNI splicing of HIF target genes

H3K9 histone demethylases in Ewing Sarcoma

Novel allosteric inhibitors of Eya 2 phosphate for treatment of metastatic breast cancer

Targeting autophagy for the treatment of triple negative breast cancer

Collaborative Project to increase accrual to cancer trials

Discovery of novel targets for young patients with colorectal cancer

Profile specific HDAC inhibitors for triple negative breast cancer

A dose escalation study of Ibrutinib with Lenalidomide for relapsed and refractory chronic lymphocytic leukemia/small lymphocytic lymphoma